Pulse Biosciences, Inc. (PLSE)
52.94
+4.14
(+8.50%)
USD |
NASDAQ |
Sep 09, 16:00
53.50
+0.56
(+1.07%)
After-Hours: 17:07
Pulse Biosciences Total Assets (Quarterly) : 115.56M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 115.56M |
| March 31, 2026 | 81.62M |
| December 31, 2025 | 96.11M |
| September 30, 2025 | 108.76M |
| June 30, 2025 | 120.25M |
| March 31, 2025 | 133.38M |
| December 31, 2024 | 134.06M |
| September 30, 2024 | 93.05M |
| June 30, 2024 | 40.43M |
| March 31, 2024 | 49.16M |
| December 31, 2023 | 60.80M |
| September 30, 2023 | 65.94M |
| June 30, 2023 | 74.76M |
| March 31, 2023 | 70.22M |
| December 31, 2022 | 80.60M |
| September 30, 2022 | 87.57M |
| June 30, 2022 | 40.60M |
| March 31, 2022 | 39.53M |
| December 31, 2021 | 57.50M |
| September 30, 2021 | 67.15M |
| June 30, 2021 | 80.04M |
| Date | Value |
|---|---|
| March 31, 2021 | 80.56M |
| December 31, 2020 | 44.91M |
| September 30, 2020 | 49.70M |
| June 30, 2020 | 58.38M |
| March 31, 2020 | 31.84M |
| December 31, 2019 | 41.92M |
| September 30, 2019 | 48.70M |
| June 30, 2019 | 57.03M |
| March 31, 2019 | 63.45M |
| December 31, 2018 | 70.64M |
| September 30, 2018 | 32.73M |
| June 30, 2018 | 39.53M |
| March 31, 2018 | 44.80M |
| December 31, 2017 | 49.82M |
| September 30, 2017 | 54.12M |
| June 30, 2017 | 27.95M |
| March 31, 2017 | 28.57M |
| December 31, 2016 | 26.31M |
| September 30, 2016 | 28.83M |
| June 30, 2016 | 31.06M |
| March 31, 2016 | 12.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Accuray, Inc. | 443.68M |
| Micron Solutions, Inc. | -- |
| Orthofix Medical, Inc. | 873.02M |
| ResMed, Inc. | 8.966B |
| Rockwell Medical, Inc. | 56.53M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 16.06M |
| Shareholders Equity (Quarterly) | 99.50M |
| Debt to Equity Ratio | 0.0681 |
| Current Ratio | 9.628 |
| Net Debt Paydown Yield | 0.02% |